Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 72
Filter
1.
Dev Dyn ; 250(7): 1036-1050, 2021 07.
Article in English | MEDLINE | ID: mdl-33452727

ABSTRACT

BACKGROUND: Pharyngeal arches (PA) are sequentially generated in an anterior-to-posterior order. Ripply3 is essential for posterior PA development in mouse embryos and its expression is sequentially activated in ectoderm and endoderm prior to formation of each PA. Since the PA phenotype of Ripply3 knockout (KO) mice is similar to that of retinoic acid (RA) signal-deficient embryos, we investigated the relationship between RA signaling and Ripply3 in mouse embryos. RESULTS: In BMS493 (pan-RAR antagonist) treated embryos, which are defective in third and fourth PA development, Ripply3 expression is decreased in the region posterior to PA2 at E9.0. This expression remains and its distribution is expanded posteriorly at E9.5. Conversely, high dose RA exposure does not apparently change its expression at E9.0 and 9.5. Knockout of retinaldehyde dehydrogenase 2 (Raldh2), which causes more severe PA defect, attenuates sequential Ripply3 expression at PA1 and reduces its expression level. EGFP reporter expression driven by a 6 kb Ripply3 promoter fragment recapitulates the endogenous Ripply3 mRNA expression during PA development in wild-type, but its distribution is expanded posteriorly in BMS493-treated and Raldh2 KO embryos. CONCLUSION: Spatio-temporal regulation of Ripply3 expression by RA signaling is indispensable for the posterior PA development in mouse.


Subject(s)
Branchial Region/embryology , Repressor Proteins/genetics , Tretinoin/metabolism , Animals , Benzoates/pharmacology , Branchial Region/drug effects , Branchial Region/metabolism , Embryo, Mammalian , Female , Gene Expression Regulation, Developmental/drug effects , Mice , Mice, Inbred ICR , Mice, Transgenic , Morphogenesis/drug effects , Morphogenesis/genetics , Pregnancy , Repressor Proteins/metabolism , Retinoic Acid Receptor alpha/antagonists & inhibitors , Signal Transduction/drug effects , Signal Transduction/physiology , Stilbenes/pharmacology , Tretinoin/pharmacology , Tretinoin/physiology
2.
Dev Cell ; 53(3): 344-357.e5, 2020 05 04.
Article in English | MEDLINE | ID: mdl-32302545

ABSTRACT

Information flow through neural circuits often requires their organization into topographic maps in which the positions of cell bodies and synaptic targets correspond. To understand how topographic map development is controlled, we examine the mechanism underlying targeting of vagus motor axons to the pharyngeal arches in zebrafish. We reveal that retinoic acid organizes topography by specifying anterior-posterior identity in vagus motor neurons. We then show that chemoattractant signaling between Hgf and Met is required for vagus innervation of the pharyngeal arches. Finally, we find that retinoic acid controls the spatiotemporal dynamics of Hgf/Met signaling to coordinate axon targeting with the developmental progression of the pharyngeal arches and show that experimentally altering the timing of Hgf/Met signaling is sufficient to redirect axon targeting and disrupt the topographic map. These findings establish a mechanism of topographic map development in which the regulation of chemoattractant signaling in space and time guides axon targeting.


Subject(s)
Gene Expression Regulation, Developmental/drug effects , Hepatocyte Growth Factor/metabolism , Proto-Oncogene Proteins c-met/metabolism , Tretinoin/pharmacology , Vagus Nerve/physiology , Zebrafish Proteins/metabolism , Zebrafish/physiology , Animals , Branchial Region/drug effects , Branchial Region/physiology , Hepatocyte Growth Factor/genetics , Keratolytic Agents/pharmacology , Proto-Oncogene Proteins c-met/genetics , Signal Transduction , Spatio-Temporal Analysis , Vagus Nerve/drug effects , Zebrafish Proteins/genetics
3.
Cells ; 8(5)2019 05 08.
Article in English | MEDLINE | ID: mdl-31072010

ABSTRACT

Aquaporins (AQPs) facilitate transmembrane water and solute transport, and in addition to contributing to transepithelial water transport, they safeguard cell volume homeostasis. This study examined the expression and localization of AQP1 and AQP3 in the gills of Japanese medaka (Oryzias latipes) in response to osmotic challenges and osmoregulatory hormones, cortisol, and prolactin (PRL). AQP3 mRNA was inversely regulated in response to salinity with high levels in ion-poor water (IPW), intermediate levels in freshwater (FW), and low levels in seawater (SW). AQP3 protein levels decreased upon SW acclimation. By comparison, AQP1 expression was unaffected by salinity. In ex vivo gill incubation experiments, AQP3 mRNA was stimulated by PRL in a time- and dose-dependent manner but was unaffected by cortisol. In contrast, AQP1 was unaffected by both PRL and cortisol. Confocal microscopy revealed that AQP3 was abundant in the periphery of gill filament epithelial cells and co-localized at low intensity with Na+,K+-ATPase in ionocytes. AQP1 was present at a very low intensity in most filament epithelial cells and red blood cells. No epithelial cells in the gill lamellae showed immunoreactivity to AQP3 or AQP1. We suggest that both AQPs contribute to cellular volume regulation in the gill epithelium and that AQP3 is particularly important under hypo-osmotic conditions, while expression of AQP1 is constitutive.


Subject(s)
Aquaporin 1/metabolism , Aquaporin 3/metabolism , Branchial Region/metabolism , Oryzias/metabolism , Animals , Aquaporin 1/genetics , Aquaporin 3/genetics , Branchial Region/drug effects , Erythrocytes/drug effects , Erythrocytes/metabolism , Fresh Water , Gills/diagnostic imaging , Gills/drug effects , Gills/metabolism , Hydrocortisone/pharmacology , Imaging, Three-Dimensional , Oryzias/genetics , Osmosis , Prolactin/pharmacology , Protein Transport , RNA, Messenger/genetics , RNA, Messenger/metabolism , Seawater , Sheep
4.
Aquat Toxicol ; 203: 28-39, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30075440

ABSTRACT

Feminizing endocrine disrupting compounds (EDCs) affect the growth and development of teleost fishes. The major regulator of growth performance, the growth hormone (Gh)/insulin-like growth-factor (Igf) system, is sensitive to estrogenic compounds and mediates certain physiological and potentially behavioral consequences of EDC exposure. Igf binding proteins (Igfbps) are key modulators of Igf activity, but their alteration by EDCs has not been examined. We investigated two life-stages (fry and smolts) of Atlantic salmon (Salmo salar), and characterized how the Gh/Igf/Igfbp system responded to waterborne 17α-ethinylestradiol (EE2), 17ß-estradiol (E2) and 4-nonylphenol (NP). Fry exposed to EE2 and NP for 21 days had increased hepatic vitellogenin (vtg) mRNA levels while hepatic estrogen receptor α (erα), gh receptor (ghr), igf1 and igf2 mRNA levels were decreased. NP-exposed fry had reduced body mass and total length compared to controls. EE2 and NP reduced hepatic igfbp1b1, -2a, -2b1, -4, -5b2 and -6b1, and stimulated igfbp5a. In smolts, hepatic vtg mRNA levels were induced following 4-day exposures to all three EDCs, while erα only responded to EE2 and E2. EDC exposures did not affect body mass or fork length; however, EE2 diminished plasma Gh and Igf1 levels in parallel with reductions in hepatic ghr and igf1. In smolts, EE2 and E2 diminished hepatic igfbp1b1, -4 and -6b1, and stimulated igfbp5a. There were no signs of compromised ionoregulation in smolts, as indicated by unchanged branchial ion pump/transporter mRNA levels. We conclude that hepatic igfbps respond (directly and/or indirectly) to environmental estrogens during two key life-stages of Atlantic salmon, and thus may modulate the growth and development of exposed individuals.


Subject(s)
Estradiol/toxicity , Ethinyl Estradiol/toxicity , Insulin-Like Growth Factor Binding Proteins/metabolism , Phenols/toxicity , Salmo salar/metabolism , Animals , Body Weight/drug effects , Branchial Region/drug effects , Branchial Region/metabolism , Endocrine Disruptors/metabolism , Gene Expression Regulation, Developmental/drug effects , Growth Hormone/blood , Insulin-Like Growth Factor Binding Proteins/genetics , Insulin-Like Growth Factor I/metabolism , Liver/drug effects , Liver/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Salmo salar/anatomy & histology , Salmo salar/genetics , Salmo salar/growth & development , Vitellogenins/genetics , Vitellogenins/metabolism , Water Pollutants, Chemical/toxicity
5.
Am J Pathol ; 188(4): 1043-1058, 2018 04.
Article in English | MEDLINE | ID: mdl-29353058

ABSTRACT

Coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness (CHARGE) syndrome is a congenital disorder affecting multiple organs and mainly caused by mutations in CHD7, a gene encoding a chromatin-remodeling protein. Immunodeficiency and reduced T cells have been noted in CHARGE syndrome. However, the mechanisms underlying T lymphopenia are largely unexplored. Herein, we observed dramatic decrease of T cells in both chd7knockdown and knockout zebrafish embryos. Unexpectedly, hematopoietic stem and progenitor cells and, particularly, lymphoid progenitor cells were increased peripherally in nonthymic areas in chd7-deficient embryos, unlikely to contribute to the T-cell decrease. Further analysis demonstrated that both the organogenesis and homing function of the thymus were seriously impaired. Chd7 might regulate thymus organogenesis through modulating the development of both neural crest cell-derived mesenchyme and pharyngeal endoderm-derived thymic epithelial cells. The expression of foxn1, a central regulator of thymic epithelium, was remarkably down-regulated in the pharyngeal region in chd7-deficient embryos. Moreover, the T-cell reduction in chd7-deficient embryos was partially rescued by overexpressing foxn1, suggesting that restoring thymic epithelium may be a potential therapeutic strategy for treating immunodeficiency in CHARGE syndrome. Collectively, the results indicated that chd7 was critical for thymic development and T-lymphopenia in CHARGE syndrome may be mainly attributed to the defects of thymic organogenesis. The current finding may benefit the diagnosis and therapy of T lymphopenia and immunodeficiency in CHARGE syndrome.


Subject(s)
DNA Helicases/metabolism , DNA-Binding Proteins/metabolism , Organogenesis , T-Lymphocytes/cytology , Thymus Gland/cytology , Thymus Gland/growth & development , Zebrafish Proteins/metabolism , Zebrafish/metabolism , Animals , Animals, Genetically Modified , Apoptosis/drug effects , Base Sequence , Bone Morphogenetic Proteins/metabolism , Branchial Region/drug effects , Branchial Region/embryology , Cell Movement/drug effects , Cell Proliferation/drug effects , Chemokines/metabolism , DNA Helicases/deficiency , DNA-Binding Proteins/deficiency , Embryo, Nonmammalian/metabolism , Epithelial Cells/metabolism , Forkhead Transcription Factors/metabolism , Hematopoietic Stem Cells/metabolism , Morpholinos/pharmacology , Mutation/genetics , Neural Crest/pathology , Phenotype , Signal Transduction , Zebrafish/embryology , Zebrafish Proteins/deficiency
6.
Reprod Toxicol ; 67: 85-99, 2017 01.
Article in English | MEDLINE | ID: mdl-27915011

ABSTRACT

In this study, we identify gene targets and cellular events mediating the teratogenic action(s) of 5-Aza-2'-deoxycytidine (AzaD), an inhibitor of DNA methylation, on secondary palate development. Exposure of pregnant mice (on gestation day (GD) 9.5) to AzaD for 12h resulted in the complete penetrance of cleft palate (CP) in fetuses. Analysis of cells of the embryonic first branchial arch (1-BA), in fetuses exposed to AzaD, revealed: 1) significant alteration in expression of genes encoding several morphogenetic factors, cell cycle inhibitors and regulators of apoptosis; 2) a decrease in cell proliferation; and, 3) an increase in apoptosis. Pyrosequencing of selected genes, displaying pronounced differential expression in AzaD-exposed 1-BAs, failed to reveal significant alterations in CpG methylation levels in their putative promoters or gene bodies. CpG methylation analysis suggested that the effects of AzaD on gene expression were likely indirect.


Subject(s)
Azacitidine/analogs & derivatives , Branchial Region/drug effects , Cleft Palate/chemically induced , Embryonic Development/drug effects , Gene Expression Regulation, Developmental/drug effects , Animals , Apoptosis/drug effects , Apoptosis/genetics , Azacitidine/toxicity , Branchial Region/embryology , Branchial Region/pathology , Cell Proliferation/drug effects , Cleft Palate/embryology , Cleft Palate/genetics , Cleft Palate/pathology , DNA Methylation/drug effects , Decitabine , Embryonic Development/genetics , Female , Gene Expression Profiling , Gestational Age , Mice, Inbred ICR , Pregnancy
7.
Reprod Toxicol ; 67: 100-110, 2017 01.
Article in English | MEDLINE | ID: mdl-27923600

ABSTRACT

Defects in development of the secondary palate, which arise from the embryonic first branchial arch (1-BA), can cause cleft palate (CP). Administration of 5-Aza-2'-deoxycytidine (AzaD), a demethylating agent, to pregnant mice on gestational day 9.5 resulted in complete penetrance of CP in fetuses. Several genes critical for normal palatogenesis were found to be upregulated in 1-BA, 12h after AzaD exposure. MethylCap-Seq (MCS) analysis identified several differentially methylated regions (DMRs) in DNA extracted from AzaD-exposed 1-BAs. Hypomethylated DMRs did not correlate with the upregulation of genes in AzaD-exposed 1-BAs. However, most DMRs were associated with endogenous retroviral elements. Expression analyses suggested that interferon signaling was activated in AzaD-exposed 1-BAs. Our data, thus, suggest that a 12-h in utero AzaD exposure demethylates and activates endogenous retroviral elements in the 1-BA, thereby triggering an interferon-mediated response. This may result in the dysregulation of key signaling pathways during palatogenesis, causing CP.


Subject(s)
Azacitidine/analogs & derivatives , Branchial Region/drug effects , Cleft Palate/chemically induced , DNA Methylation/drug effects , Embryonic Development/drug effects , Gene Expression Regulation, Developmental/drug effects , Animals , Azacitidine/toxicity , Branchial Region/embryology , Cleft Palate/embryology , Cleft Palate/genetics , Decitabine , Embryonic Development/genetics , Female , Gene Expression Profiling , Gestational Age , Mice, Inbred ICR , Pregnancy
8.
J Exp Biol ; 219(Pt 15): 2289-99, 2016 08 01.
Article in English | MEDLINE | ID: mdl-27207642

ABSTRACT

Dissolved organic matter (DOM) is both ubiquitous and diverse in composition in natural waters, but its effects on the branchial physiology of aquatic organisms have received little attention relative to other variables (e.g. pH, hardness, salinity, alkalinity). Here, we investigated the effects of four chemically distinct DOM isolates (three natural, one commercial, ranging from autochthonous to highly allochthonous, all at ∼6 mg C l(-1)) on the physiology of gill ionoregulation and nitrogenous waste excretion in zebrafish acclimated to either circumneutral (7.0-8.0) or acidic pH (5.0). Overall, lower pH tended to increase net branchial ammonia excretion, net K(+) loss and [(3)H]PEG-4000 clearance rates (indicators of transcellular and paracellular permeability, respectively). However, unidirectional Na(+) efflux, urea excretion and drinking rates were unaffected. DOM sources tended to stimulate unidirectional Na(+) influx rate and exerted subtle effects on the concentration-dependent kinetics of Na(+) uptake, increasing maximum transport capacity. All DOM sources reduced passive Na(+) efflux rates regardless of pH, but exerted negligible effects on nitrogenous waste excretion, drinking rate, net K(+) loss or [(3)H]PEG-4000 clearance, so the mechanism of Na(+) loss reduction remains unclear. Overall, these actions appear beneficial to ionoregulatory homeostasis in zebrafish, and some may be related to physico-chemical properties of the DOM sources. They are very different from those seen in a recent parallel study on Daphnia magna using the same DOM isolates, indicating that DOM actions may be both species and DOM specific.


Subject(s)
Nitrogen/metabolism , Organic Chemicals/pharmacology , Sodium/metabolism , Zebrafish/metabolism , Ammonia/metabolism , Animals , Branchial Region/drug effects , Branchial Region/metabolism , Carbon/analysis , Drinking Behavior/drug effects , Humic Substances/analysis , Hydrogen-Ion Concentration , Kinetics , Permeability/drug effects , Polyethylene Glycols/pharmacology , Potassium/metabolism , Solubility , Tritium/metabolism , Urea/metabolism
9.
Reprod Toxicol ; 58: 140-8, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26482727

ABSTRACT

Orofacial clefts, the most prevalent of developmental anomalies, occur with a frequency of 1 in 700 live births. Maternal cigarette smoking during pregnancy represents a risk factor for having a child with a cleft lip and/or cleft palate. Using primary cultures of first branchial arch-derived cells (1-BA cells), which contribute to the formation of the lip and palate, the present study addressed the hypothesis that components of cigarette smoke alter global DNA methylation, and/or expression of DNA methyltransferases (Dnmts) and various methyl CpG-binding proteins. Primary cultures of 1-BA cells, exposed to 80µg/mL cigarette smoke extract (CSE) for 24h, exhibited a >13% decline in global DNA methylation and triggered proteasomal-mediated degradation of Dnmts (DNMT-1 and -3a), methyl CpG binding protein 2 (MeCP2) and methyl-CpG binding domain protein 3 (MBD-3). Pretreatment of 1-BA cells with the proteasomal inhibitor MG-132 completely reversed such degradation. Collectively, these data allow the suggestion of a potential epigenetic mechanism underlying maternal cigarette smoke exposure-induced orofacial clefting.


Subject(s)
Branchial Region/enzymology , Cleft Lip/genetics , Cleft Palate/genetics , DNA (Cytosine-5-)-Methyltransferases/metabolism , DNA Methylation , DNA-Binding Proteins/metabolism , Epigenesis, Genetic , Methyl-CpG-Binding Protein 2/metabolism , Proteasome Endopeptidase Complex/metabolism , Smoke/adverse effects , Tobacco Products/adverse effects , Transcription Factors/metabolism , Animals , Branchial Region/drug effects , Branchial Region/pathology , Cells, Cultured , Cleft Lip/enzymology , Cleft Palate/enzymology , CpG Islands , DNA (Cytosine-5-)-Methyltransferase 1 , DNA Methylation/drug effects , DNA Methyltransferase 3A , Epigenesis, Genetic/drug effects , Female , Mice, Inbred ICR , Pregnancy , Primary Cell Culture , Proteasome Inhibitors/pharmacology , Proteolysis , Risk Factors , Smoking/adverse effects
10.
Article in English | MEDLINE | ID: mdl-23651928

ABSTRACT

This study examined the distribution and orientation of gill O(2) chemoreceptors in Oreochromis niloticus and their role in cardiorespiratory responses to graded hypoxia. Intact fish, and a group with the first gill arch excised (operated), were submitted to graded hypoxia and their cardiorespiratory responses (oxygen uptake - V˙O(2) , breathing frequency - fR, ventilatory stroke volume - VT, gill ventilation - V˙G, O(2) extraction from the ventilatory current - EO(2) , and heart rate - fH) were compared. Their responses to bolus injections of NaCN into the bloodstream (internal) or ventilatory water stream (external) were also determined. The V˙O(2) of operated fish was significantly lower at the deepest levels of hypoxia. Neither reflex bradycardia nor ventilatory responses were completely abolished by bilateral excision of the first gill arch. EO(2) of the operated group was consistently lower than the intact group. The responses to internal and external NaCN included transient decreases in fH and increases in fR and Vamp (ventilation amplitude). These cardiorespiratory responses were attenuated but not abolished in the operated group, indicating that chemoreceptors are not restricted to the first gill arch, and are sensitive to oxygen levels in both blood and water.


Subject(s)
Branchial Region/metabolism , Chemoreceptor Cells/metabolism , Cichlids/metabolism , Heart/physiopathology , Hypoxia/physiopathology , Lung/physiopathology , Oxygen/metabolism , Animals , Branchial Region/drug effects , Branchial Region/physiopathology , Chemoreceptor Cells/drug effects , Gills/drug effects , Gills/physiopathology , Heart/drug effects , Heart Rate/drug effects , Hypoxia/metabolism , Lung/metabolism , Oxygen Consumption/drug effects , Respiration/drug effects , Sodium Cyanide/pharmacology
11.
Cleft Palate Craniofac J ; 48(4): 355-62, 2011 Jul.
Article in English | MEDLINE | ID: mdl-20815727

ABSTRACT

OBJECTIVE: The purpose of the present study was to identify the potential effect of prenatal vitamin B12 administration on retinoic acid (RA)-induced early craniofacial abnormalities in mice and to investigate the possible mechanisms by which vitamin B12 reduces malformations. DESIGN: In our study, whole embryo culture was used to explore the effect of vitamin B12 on mouse embryos during the critical period of organogenesis. All embryos were exposed to 0.4 µM RA and different concentrations of vitamin B12 and scored for their growth in the branchial region at the end of a 48-hour culture period. The endothelin-1 (ET-1)/dHAND protein expression levels in the first branchial arch were investigated using an immunohistochemical method. RESULTS: In the whole embryo culture, 100 and 10 µM vitamin B12 dose-dependently prevented branchial region malformations and decreased craniofacial defects by 90.5% and 77.3%, respectively. ET-1 and dHAND protein levels were significantly increased in vitamin B12-supplemented embryos compared to the RA-exposed group in embryonic branchial region. CONCLUSIONS: These results suggest that vitamin B12 may prevent RA-induced craniofacial abnormalities via prevention of an RA-induced decrease of ET-1 and dHAND protein levels in the branchial region during the organogenic period. This study may shed new light on preventing craniofacial abnormalities.


Subject(s)
Craniofacial Abnormalities/prevention & control , Tretinoin/adverse effects , Vitamin B 12/therapeutic use , Vitamin B Complex/therapeutic use , Animals , Basic Helix-Loop-Helix Transcription Factors/analysis , Basic Helix-Loop-Helix Transcription Factors/drug effects , Branchial Region/drug effects , Craniofacial Abnormalities/chemically induced , Dose-Response Relationship, Drug , Embryo Culture Techniques , Embryonic Development/drug effects , Endothelin-1/analysis , Endothelin-1/drug effects , Facial Bones/abnormalities , Facial Bones/drug effects , Female , Male , Mice , Mice, Inbred ICR , Microcephaly/chemically induced , Microcephaly/prevention & control , Neural Tube Defects/chemically induced , Neural Tube Defects/prevention & control , Vitamin B 12/administration & dosage , Vitamin B Complex/administration & dosage
12.
Reprod Toxicol ; 30(4): 583-90, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20708075

ABSTRACT

Three groups of compounds: (i) active peroxides (artemisinin and arterolene), (ii) inactive non-peroxidic derivatives (deoxyartemisinin and carbaOZ277) and (iii) inactive peroxide (OZ381) were tested by WEC system to provide insights into the relationship between chemical structure and embryotoxic potential, and to assess the relationship between embryotoxicity and antimalarial activity. Deoxyartemisinin, OZ381 and carbaOZ277 did not affect rat embryonic development. Artemisinin and arterolane affected primarily nucleated red blood cells (RBCs), inducing anemia and subsequent tissue damage in rat embryos, with NOELs for RBC damage at 0.1 and 0.175µg/mL, respectively. These data support the idea that only active antimalarial peroxides are able to interfere with normal embryonic development. In an attempt to establish whether and to what extent activity as antimalarials and embryotoxicity can be divorced, IC(50)s for activity in Plasmodium falciparum strains and the NOELs for RBCs were compared. From this comparison, arterolane showed a better safety margin than artemisinin.


Subject(s)
Antimalarials/toxicity , Embryo, Mammalian/drug effects , Peroxides/toxicity , Teratogens/toxicity , Adamantane/analogs & derivatives , Adamantane/toxicity , Animals , Antimalarials/chemistry , Artemisinins/toxicity , Branchial Region/drug effects , Branchial Region/pathology , Drug Evaluation, Preclinical/methods , Embryo Culture Techniques , Embryo, Mammalian/blood supply , Embryo, Mammalian/pathology , Embryonic Development/drug effects , Erythrocytes/drug effects , Erythrocytes/pathology , Heterocyclic Compounds, 1-Ring/chemistry , Heterocyclic Compounds, 1-Ring/toxicity , Inhibitory Concentration 50 , No-Observed-Adverse-Effect Level , Peroxides/chemistry , Plasmodium falciparum/drug effects , Rats , Spiro Compounds/chemistry , Spiro Compounds/toxicity , Structure-Activity Relationship , Teratogens/chemistry , Yolk Sac/blood supply , Yolk Sac/drug effects , Yolk Sac/pathology
13.
Chin Med J (Engl) ; 123(9): 1182-9, 2010 May 05.
Article in English | MEDLINE | ID: mdl-20529560

ABSTRACT

BACKGROUND: Tbx1 is the major candidate gene for DiGeorge syndrome (DGS). Similar to defects observed in DGS patients, the structures disrupted in Tbx1(-/-) animal models are derived from the neural crest cells during development. Although the morphological phenotypes of some Tbx1 knock-down animal models have been well described, analysis of the cardiac performance is limited. Therefore, myocardial performance was explored in Tbx1 morpholino injected zebrafish embryos. METHODS: To elucidate these issues, Tbx1 specific morpholino was used to reduce the function of Tbx1 in zebrafish. The differentiation of the myocardial cells was observed using whole mount in situ hybridization. Heart rates were observed and recorded under the microscope from 24 to 72 hours post fertilization (hpf). The cardiac performance was analyzed by measuring ventricular shortening fraction and atrial shortening fraction. RESULTS: Tbx1 morpholino injected embryos were characterized by defects in the pharyngeal arches, otic vesicle, aortic arches and thymus. In addition, Tbx1 knock down reduced the amount of pharyngeal neural crest cells in zebrafish. Abnormal cardiac morphology was visible in nearly 20% of the Tbx1 morpholino injected embryos. The hearts in these embryos did not loop or loop incompletely. Importantly, cardiac performance and heart rate were reduced in Tbx1 morpholino injected embryos. CONCLUSIONS: Tbx1 might play an essential role in the development of pharyngeal neural crest cells in zebrafish. Cardiac performance is impaired by Tbx1 knock down in zebrafish.


Subject(s)
Heart/drug effects , Heart/physiology , T-Box Domain Proteins/metabolism , Zebrafish Proteins/metabolism , Zebrafish/metabolism , Animals , Branchial Region/cytology , Branchial Region/drug effects , Heart Rate/drug effects , In Situ Hybridization , Myocardium/cytology , Neural Crest/cytology , Neural Crest/drug effects , Oligonucleotides, Antisense/pharmacology , T-Box Domain Proteins/antagonists & inhibitors , Thymus Gland/cytology , Thymus Gland/drug effects , Zebrafish/embryology , Zebrafish Proteins/antagonists & inhibitors
14.
Fish Physiol Biochem ; 36(2): 135-40, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20467854

ABSTRACT

In this study the effects of growth hormone (GH) on silver sea bream branchial heat-shock protein 70 (HSP70) expression was investigated using in-vivo and in-vitro experiments. For in-vivo experiments, sea bream were administered recombinant bream GH or the GH secretagogue hexarelin. Pituitary levels of GH were unchanged in fish administered exogenous GH but decreased on hexarelin administration, in comparison with saline controls. Levels of HSP70 were measured using immunoanalysis and it was found that both GH and hexarelin administration caused a significant decrease in branchial HSP70 abundance. For in-vitro analysis, branchial filaments were exposed to a range of GH concentrations (1, 10, and 100 ng/ml) and it was found that HSP70 levels were significantly lowered in all cases. This study adds to the growing body of evidence surrounding the importance of hormones in regulating heat-shock protein expression in fish.


Subject(s)
Fish Proteins/metabolism , Growth Hormone/pharmacology , HSP70 Heat-Shock Proteins/metabolism , Sea Bream/metabolism , Animals , Branchial Region/drug effects , Branchial Region/metabolism , Fish Proteins/pharmacology , Gills/drug effects , Gills/metabolism , Growth Hormone/metabolism , Immunohistochemistry , In Vitro Techniques , Oligopeptides/pharmacology , Pituitary Gland/metabolism , Recombinant Proteins/pharmacology
15.
Mech Dev ; 127(7-8): 329-44, 2010.
Article in English | MEDLINE | ID: mdl-20406684

ABSTRACT

Zebrafish tgfbeta3 is strongly expressed in a subpopulation of the migrating neural crest cells, developing pharyngeal arches and neurocranial cartilages. To study the regulatory role of tgfbeta3 in head skeletal formation, we knocked down tgfbeta3 in zebrafish and found impaired craniofacial chondrogenesis, evident by malformations in selected neurocranial and pharyngeal arch cartilages. Over-expressing tgfbeta3 in embryos resulted in smaller craniofacial cartilages without any gross malformations. These defects suggest that tgfbeta3 is required for normal chondrogenesis. To address the cellular mechanisms that lead to the observed malformations, we analyzed cranial neural crest development in morphant and tgfbeta3 over-expressing fish. We observed reduced pre-migratory and migratory cranial neural crest, the precursors of the neurocranial cartilage and pharyngeal arches, in tgfbeta3 knockdown embryos. In contrast, only the migratory neural crest was reduced in embryos over-expressing tgfbeta3. This raised the possibility that the reduced number of cranial neural crest cells is a result of increased apoptosis. Consistent with this, markedly elevated TUNEL staining in the midbrain and hindbrain, and developing pharyngeal arch region was observed in morphants, while tgfbeta3 over-expressing embryos showed marginally increased apoptosis in the developing pharyngeal arch region. We propose that both Tgfbeta3 suppression and over-expression result in reduced chondrocyte and osteocyte formation, but to different degrees and through different mechanisms. In Tgfbeta3 suppressed embryos, this is due to impaired formation and survival of a subpopulation of cranial neural crest cells through markedly increased apoptosis in regions containing the cranial neural crest cells, while in Tgfbeta3 over-expressing embryos, the milder phenotype is also due to a slightly elevated apoptosis in these regions. Therefore, proper cranial neural crest formation and survival, and ultimately craniofacial chondrogenesis and osteogenesis, are dependent on tight regulation of Tgfbeta3 protein levels in zebrafish.


Subject(s)
Chondrogenesis , Neural Crest/cytology , Neural Crest/embryology , Osteogenesis , Skull/embryology , Transforming Growth Factor beta3/metabolism , Zebrafish/embryology , Animals , Apoptosis/drug effects , Branchial Region/drug effects , Branchial Region/metabolism , Cartilage/drug effects , Cartilage/embryology , Cartilage/metabolism , Cell Differentiation/drug effects , Cell Movement/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Chondrogenesis/drug effects , Chondrogenesis/genetics , Embryo, Nonmammalian/drug effects , Embryo, Nonmammalian/metabolism , Gene Expression Regulation, Developmental/drug effects , Gene Knockdown Techniques , Neural Crest/drug effects , Neural Crest/metabolism , Oligonucleotides, Antisense/pharmacology , Osteoblasts/cytology , Osteoblasts/drug effects , Osteoblasts/metabolism , Osteogenesis/drug effects , Osteogenesis/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Skull/cytology , Skull/drug effects , Skull/metabolism , Transforming Growth Factor beta3/deficiency , Transforming Growth Factor beta3/genetics , Zebrafish/genetics , Zebrafish Proteins/genetics , Zebrafish Proteins/metabolism
16.
Dev Dyn ; 239(4): 1136-44, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20235221

ABSTRACT

Folate supplementation reduces the incidence of congenital heart defects, but the nature of this protective mechanism remains unclear. Immunolabeling demonstrated that the neural tube and neural crest (NC) cells were rich in the high-affinity folate receptor FOLR1and during the early stages of development FOLR1 was found principally in these cells. Suppression of Folr1 expression in the nascent cardiac NC by site-directed short-interfering RNA (siRNA) altered cardiac NC cell mitosis and subsequent migration patterns leading to abnormal development of the pharyngeal arch arteries (PAA) and outflow tract. qPCR analysis demonstrated that the siRNA treatment significantly reduced Folr1 24 hr after treatment. These treatments also significantly reduced mitosis in the neural tube, but adjacent, nontreated areas were unaffected. In summary, a brief reduction in the expression of Folr1 during a critical stage of NC development had long-term consequences for the development of the PAA and outflow tract.


Subject(s)
Carrier Proteins/physiology , Cell Movement/genetics , Heart/embryology , Neural Crest/metabolism , RNA, Small Interfering/pharmacology , Receptors, Cell Surface/physiology , Animals , Animals, Genetically Modified , Arteries/drug effects , Arteries/embryology , Arteries/metabolism , Branchial Region/blood supply , Branchial Region/drug effects , Branchial Region/embryology , Branchial Region/metabolism , Carrier Proteins/antagonists & inhibitors , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Movement/drug effects , Chick Embryo , Folate Receptors, GPI-Anchored , Gene Expression Regulation, Developmental/drug effects , Gene Knockdown Techniques , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Heart/drug effects , Models, Animal , Neural Crest/drug effects , Neural Crest/embryology , Neural Crest/physiology , Receptors, Cell Surface/antagonists & inhibitors , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism , Substrate Specificity , Time Factors
17.
Cell Death Dis ; 1: e46, 2010 May 27.
Article in English | MEDLINE | ID: mdl-21364652

ABSTRACT

Fetal alcohol syndrome (FAS) is caused by maternal alcohol consumption during pregnancy. The reason why specific embryonic tissues are sensitive toward ethanol is not understood. We found that in neural crest-derived cell (NCC) cultures from the first branchial arch of E10 mouse embryos, incubation with ethanol increases the number of apoptotic cells by fivefold. Apoptotic cells stain intensely for ceramide, suggesting that ceramide-induced apoptosis mediates ethanol damage to NCCs. Apoptosis is reduced by incubation with CDP-choline (citicoline), a precursor for the conversion of ceramide to sphingomyelin. Consistent with NCC cultures, ethanol intubation of pregnant mice results in ceramide elevation and increased apoptosis of NCCs in vivo. Ethanol also increases the protein level of prostate apoptosis response 4 (PAR-4), a sensitizer to ceramide-induced apoptosis. Prenatal ethanol exposure is concurrent with malformation of parietal bones in 20% of embryos at day E18. Meninges, a tissue complex derived from NCCs, is disrupted and generates reduced levels of TGF-ß1, a growth factor critical for bone and brain development. Ethanol-induced apoptosis of NCCs leading to defects in the meninges may explain the simultaneous presence of cranial bone malformation and cognitive retardation in FAS. In addition, our data suggest that treatment with CDP-choline may alleviate the tissue damage caused by alcohol.


Subject(s)
Apoptosis/drug effects , Ceramides/pharmacology , Ethanol/toxicity , Neural Crest/drug effects , Neural Crest/pathology , Prenatal Exposure Delayed Effects/pathology , Skull/embryology , Animals , Branchial Region/drug effects , Branchial Region/pathology , Cell Count , Ethanol/administration & dosage , Female , Hydrolysis/drug effects , Mice , Mice, Inbred C57BL , Models, Biological , Pregnancy , Receptors, Thrombin/metabolism , Skull/abnormalities , Skull/drug effects , Skull/pathology , Sphingomyelins/metabolism , Transforming Growth Factor beta1/metabolism
18.
Dev Biol ; 325(1): 60-70, 2009 Jan 01.
Article in English | MEDLINE | ID: mdl-18929555

ABSTRACT

Retinoic acid (RA) signaling regulates multiple aspects of vertebrate embryonic development and tissue patterning, in part through the local availability of nuclear hormone receptors called retinoic acid receptors (RARs) and retinoid receptors (RXRs). RAR/RXR heterodimers transduce the RA signal, and loss-of-function studies in mice have demonstrated requirements for distinct receptor combinations at different stages of embryogenesis. However, the tissue-specific functions of each receptor and their individual contributions to RA signaling in vivo are only partially understood. Here we use morpholino oligonucleotides to deplete the four known zebrafish RARs (raraa, rarab, rarga, and rargb). We show that while all four are required for anterior-posterior patterning of rhombomeres in the hindbrain, there are unique requirements for rarga in the cranial mesoderm for hindbrain patterning, and rarab in lateral plate mesoderm for specification of the pectoral fins. In addition, the alpha subclass (raraa, rarab) is RA inducible, and of these only raraa expression is RA-dependent, suggesting that these receptors establish a region of particularly high RA signaling through positive-feedback. These studies reveal novel tissue-specific roles for RARs in controlling the competence and sensitivity of cells to respond to RA.


Subject(s)
Branchial Region/metabolism , Extremities/embryology , Receptors, Retinoic Acid/metabolism , Rhombencephalon/metabolism , Zebrafish/embryology , Zebrafish/metabolism , Animal Structures/cytology , Animal Structures/drug effects , Animal Structures/embryology , Animal Structures/metabolism , Animals , Body Patterning/drug effects , Branchial Region/cytology , Branchial Region/drug effects , Branchial Region/embryology , Embryo, Nonmammalian/cytology , Embryo, Nonmammalian/drug effects , Embryo, Nonmammalian/metabolism , Gene Expression Profiling , Gene Expression Regulation, Developmental/drug effects , Homeodomain Proteins/metabolism , Models, Biological , Organ Specificity/drug effects , Receptors, Retinoic Acid/genetics , Rhombencephalon/cytology , Rhombencephalon/drug effects , Rhombencephalon/embryology , Tretinoin/pharmacology , Zebrafish/genetics
19.
Toxicol Sci ; 106(1): 193-205, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18660518

ABSTRACT

We have used zebrafish and 3,3',4,4',5-pentachlorobiphenyl (PCB126) to investigate the developmental toxicity of polychlorinated biphenyls (PCBs) that exert their effects through the aryl hydrocarbon receptor (AHR). We found that cardiac and neural crest (NC)-derived jaw and branchial cartilages are specifically targeted early in development. The suite of malformations, which ultimately leads to circulatory failure, includes a severely dysmorphic heart with a reduced bulbus arteriosus and abnormal atrioventricular and outflow valve formation. Early NC migration and patterning of the jaw and branchial cartilages was normal. However, the jaw and branchial cartilages failed to grow to normal size. In the heart, the ventricular myocardium showed a reduction in cell number and size. The heart and jaw/branchial phenotype could be rescued by pifithrin-alpha, a blocker of p53. However, the function of pifithrin-alpha in this model may act as a competitive inhibitor of PCB at the AHR and is likely independent of p53. Morpholinos against p53 did not rescue the phenotype, nor were zebrafish with a mutant p53-null allele resistant to PCB126 toxicity. Morpholino knockdown of cardiac troponin T, which blocks the onset of cardiac function, prevented the PCB126-induced cardiac dysmorphogenesis but not the jaw/branchial phenotype. The cardiovascular characteristics appear to be similar to hypoplastic left heart syndrome (HLHS) and introduce the potential of zebrafish as a model to study this environmentally induced cardiovascular malformation. HLHS is a severe congenital cardiovascular malformation that has previously been linked to industrial releases of dioxins and PCBs.


Subject(s)
Abnormalities, Multiple/chemically induced , Branchial Region/drug effects , Environmental Pollutants/toxicity , Heart Defects, Congenital/chemically induced , Heart Ventricles/drug effects , Neural Crest/drug effects , Polychlorinated Biphenyls/toxicity , Zebrafish/embryology , Abnormalities, Multiple/embryology , Abnormalities, Multiple/metabolism , Abnormalities, Multiple/prevention & control , Animals , Animals, Genetically Modified , Benzothiazoles/pharmacology , Body Patterning/drug effects , Branchial Region/metabolism , Cell Death , Cell Differentiation , Cell Movement , Cell Proliferation/drug effects , Heart Defects, Congenital/embryology , Heart Defects, Congenital/metabolism , Heart Defects, Congenital/prevention & control , Heart Ventricles/embryology , Heart Ventricles/metabolism , Jaw Abnormalities/chemically induced , Morpholines/metabolism , Oligonucleotides/metabolism , Phenotype , Time Factors , Toluene/analogs & derivatives , Toluene/pharmacology , Troponin T/genetics , Troponin T/metabolism , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , Zebrafish/genetics , Zebrafish/metabolism
20.
PLoS One ; 3(4): e2029, 2008 Apr 30.
Article in English | MEDLINE | ID: mdl-18446220

ABSTRACT

BACKGROUND: Among Myc family genes, c-Myc is known to have a role in neural crest specification in Xenopus and in craniofacial development in the mouse. There is no information on the function of other Myc genes in neural crest development, or about any developmental role of zebrafish Myc genes. PRINCIPAL FINDINGS: We isolated the zebrafish mych (myc homologue) gene. Knockdown of mych leads to severe defects in craniofacial development and in certain other tissues including the eye. These phenotypes appear to be caused by cell death in the neural crest and in the eye field in the anterior brain. SIGNIFICANCE: Mych is a novel factor required for neural crest cell survival in zebrafish.


Subject(s)
Neural Crest/embryology , Transcription Factors/genetics , Zebrafish Proteins/genetics , Zebrafish/embryology , Zebrafish/genetics , Amino Acid Sequence , Animals , Biomarkers/metabolism , Body Patterning/drug effects , Brain/drug effects , Brain/metabolism , Branchial Region/abnormalities , Branchial Region/drug effects , Cell Death/drug effects , DNA, Complementary/isolation & purification , Embryo, Nonmammalian/abnormalities , Embryo, Nonmammalian/drug effects , Embryo, Nonmammalian/metabolism , Gene Expression Regulation, Developmental/drug effects , Molecular Sequence Data , Neural Plate/cytology , Neural Plate/drug effects , Oligonucleotides, Antisense/pharmacology , Phenotype , Sequence Analysis, Protein , Somites/abnormalities , Somites/drug effects , Transcription Factors/chemistry , Transcription Factors/metabolism , Zebrafish Proteins/chemistry , Zebrafish Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...